Table 1.
Baseline characteristics in all patients with chronic organic mitral regurgitation and the comparisons between patients with and without pulmonary hypertension
| Variables | All patients (N = 154) | No PH (N = 113) | PH (N = 41) | P-value |
|---|---|---|---|---|
| Age (years) | 55.0 ± 16.4 | 53.4 ± 16.7 | 59.3 ± 14.8 | 0.050 |
| Male gender | 93(60.4) | 69(61.1) | 24(58.5) | 0.777 |
| Symptomatic | 58(37.7) | 34(30.1) | 24(58.5) | 0.001 |
| BMI (kg/m2) | 22.8 ± 3.4 | 22.6 ± 3.4 | 23.2 ± 3.4 | 0.362 |
| Hypertension | 61(39.6) | 43(38.1) | 18(43.9) | 0.512 |
| Diabetes mellitus | 10(6.5) | 8(7.1) | 2(4.9) | 1.0 |
| Dyslipidemia | 44(28.6) | 33(29.2) | 11(26.8) | 0.773 |
| Smoking | 46(29.9) | 36(31.9) | 10(24.4) | 0.371 |
| History of HF | 31(20.1) | 16(14.2) | 15(36.6) | 0.002 |
| Prior stroke/TIA | 8(5.2) | 7(6.2) | 1(2.4) | 0.682 |
| Betablocker | 46(30.3) | 31(27.9) | 15(36.6) | 0.302 |
| ACEI/ARB | 56(36.8) | 39(35.1) | 17(41.5) | 0.473 |
| Anticoagulant | 32(21.1) | 19(17.1) | 13(31.7) | 0.050 |
| Diuretics | 65(42.8) | 38(34.2) | 27(65.9) | <0.001 |
Data are expressed as mean ± standard deviation and number (percentage)
P-values are for comparisons between 2 groups
ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BMI body mass index, HF heart failure, PH pulmonary hypertension, TIA transient ischemic attack